Related Experiment Video
Updated: Jul 25, 2025
05:39
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
1.9K
Immunoglobulin A nephropathy in remission: a case report
Asim Mahat1, Nimesh Lageju2, Durga Neupane2
1Nepal Army Institute of Health Sciences, Kathmandu.
Annals of Medicine and Surgery (2012)
|June 26, 2023
Summary
Immunoglobulin A nephropathy, a common kidney disease, can be managed effectively. Treatment involving antihypertensives, steroids, and immunosuppressants led to symptom remission and normalized kidney function in a patient.
Area of Science:
- Nephrology
- Immunology
- Internal Medicine
Background:
- Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis.
- IgAN can lead to chronic kidney disease and end-stage renal disease if not managed properly.
- Early diagnosis and treatment are crucial for managing IgAN complications.
Purpose of the Study:
- To present a case of a military male diagnosed with Immunoglobulin A nephropathy.
- To describe the management and outcomes of a patient with a long-standing history of IgAN.
- To highlight the importance of consistent follow-up and appropriate medical intervention in IgAN management.
Main Methods:
- A 33-year-old male military personnel with a 10-year history of symptoms including fever, headache, myalgia, chills, and hematuria was evaluated.
- Diagnostic workup included laboratory tests revealing elevated serum creatinine and proteinuria, followed by a renal biopsy confirming IgAN.
- Treatment regimen comprised antihypertensives (including ACE inhibitors), steroids, immunosuppressants, and Omega-3 fatty acids.
Main Results:
- The patient achieved remission of symptoms following the prescribed treatment.
- Serum creatinine levels returned to baseline.
- Renal sonogram findings also normalized, indicating recovery of kidney function.
Conclusions:
- This case demonstrates that a comprehensive treatment approach can lead to successful management of Immunoglobulin A nephropathy.
- Routine monitoring and adherence to medication regimens are vital for limiting disease progression and preventing complications in IgAN patients.
- Effective management can restore kidney function and improve patient outcomes.
More Related Videos
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.8K
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
8.5K
Related Concept Videos
01:29Acute Kidney Injury III: Clinical Manifestations
44
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
44
01:24Nephrotic Syndrome I : Introduction
10
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
10
01:26Nephrotic Syndrome II : Assessment and Medical Management
10
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
10
01:24Nephrotic Syndrome III : Nursing Management
20
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
20
01:24Chronic Kidney Disease II: Clinical Manifestations
40
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
40
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
40
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40